Regeneron Pharmaceuticals, Inc 10-Q for FY2021 Q1
Regeneron Pharmaceuticals, Inc. (REGN)
10-Q
2021-05-06
For: 2021-03-31
View Original
Added on
April 08, 2026
About this 10-Q
Regeneron Pharmaceuticals, Inc filed this 10-Q on May 6, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.53B
- up 38.3% from $1.83B a year earlier
- Net income
- $1.12B
- up 78.5% from net income of $624.6M a year earlier
- Diluted EPS
- $10.09
- up 85.8% from $5.43 a year earlier